ArticlePharmaceuticals (Basel, Switzerland)2022
Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold.
Dan Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.